Related Experiment Videos
Primary cutaneous aspergillosis in a preterm infant
1Section of Newborn Services, Women's Hospital, University of Michigan Medical Center, Ann Arbor 48109-0254.
Abstract:
A case of primary cutaneous aspergillosis in a very low birthweight infant that responded to medical therapy is reported. Knowledge of the potential pathogenic role of this organism in neonatal skin lesions is important because of resistance to standard empirical antibacterial therapy and the potential for dissemination and deep parenchymal invasion. Surgical excision may be necessary if cutaneous aspergillosis progresses despite systemic antifungal therapy.
Insights
Primary cutaneous aspergillosis in a very low birthweight infant responded to medical therapy. Early recognition is crucial due to potential for serious complications and resistance to antibacterial treatments.
Area of Science:
- Neonatal dermatology
- Mycology
- Infectious diseases
Background:
- Primary cutaneous aspergillosis is a rare fungal infection affecting the skin.
- It can pose significant risks in vulnerable populations like neonates.
Observation:
- A case of primary cutaneous aspergillosis in a very low birthweight infant is presented.
- The infant's skin lesions showed a positive response to medical treatment.
Findings:
- The case highlights the successful medical management of cutaneous aspergillosis in a neonate.
- This underscores the importance of considering fungal infections in neonatal skin conditions.
Implications:
- Accurate diagnosis and timely antifungal therapy are critical for managing neonatal cutaneous aspergillosis.
- Awareness is essential for healthcare providers to prevent dissemination and deep-seated infections.